Ideaya Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,923 |
Gross Profit | -1,097 | -1,082 | 2,899 | |
EBITDA | -66,893 | -64,305 | -51,017 | -41,288 |
EBIT | -67,905 | -65,402 | -52,099 | -42,312 |
Net Income | -51,821 | -52,772 | -39,572 | -33,955 |
Net Change In Cash | 0 | 0 | 0 | 3,923 |
Free Cash Flow | -49,691 | -33,854 | -45,138 | -24,586 |
Cash | 400,283 | 183,049 | 108,345 | 157,018 |
Basic Shares | 86,188 | 77,962 | 75,108 | 65,246 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $23,385 | $50,931 | $27,941 | $19,538 |
Gross Profit | -106,123 | 50,931 | 27,941 | 19,538 |
EBITDA | -130,421 | -60,401 | -48,543 | -33,963 |
EBIT | -134,429 | -62,502 | -50,268 | -35,344 |
Net Income | -112,961 | -54,808 | -47,531 | -32,265 |
Net Change In Cash | 23,385 | 50,931 | 27,941 | 19,538 |
Cost of Revenue | -23,414 | 20,009 | 37,970 | |
Free Cash Flow | -117,592 | -90,618 | -58,423 | 54,970 |
Cash | 157,018 | 68,632 | 92,046 | 72,037 |
Basic Shares | 57,519 | 41,444 | 35,252 | 24,721 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.60 |
2024-06-30 | -$0.68 |
2024-03-31 | -$0.53 |
2023-12-31 | -$0.52 |
